Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Abbisko Therapeutics identifies RORC agonists

May 8, 2020

How does innate immunity remember? Not via polycomb

May 6, 2020

Neutralizing RSV

May 4, 2020

Sareum Holdings identifies TYK2 inhibitors

May 4, 2020

Promising data from compassionate care program of CAP-1002 in critical COVID-19 patients

April 30, 2020

Tetra Bio-Pharma to develop PPP-003 for management of CRS

April 29, 2020

ChAdOx1 nCoV-19 vaccine candidate enters clinical testing

April 27, 2020

In antibody ensemble, second fiddles help the neutralizing stars

April 24, 2020

Valneva and Dynavax collaborate on vaccine program for COVID-19

April 24, 2020

Favorable safety seen with MERS-CoV vaccine MVA-MERS-S in phase I study

April 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...